Skip to main content
Log in

Carotid intima-media thickness and serum leptin in psoriasis

Karotis-Intima-Media-Dicke und Serumleptin bei Psoriasis

  • Original article
  • Published:
Herz Aims and scope Submit manuscript

Abstract

Background

Psoriasis, a chronic inflammatory immune disorder, has been linked to increased cardiovascular mortality and morbidity. Leptin, an obesity-related peptide, has been shown to exert direct effects on the vascular endothelium and on vascular smooth muscle cells. Carotid intima-media thickness (IMT) measurement is a promising tool for detecting atherosclerosis in its pre-occlusive/subclinical phase.

Objective

The objective of the study was to evaluate carotid IMT and serum leptin levels in psoriatic patients as an indicator of subclinical atherosclerosis.

Materials and methods

The study was conducted in 50 psoriatic patients and 10 healthy controls. The clinical severity of skin affection in psoriatic patients was estimated using the psoriatic area and severity index (PASI). Serum leptin levels (ng\ml) and lipid profiles [including serum triglyceride (TG), serum low density lipoproteins (LDL) and serum high density lipoproteins (HDL)] were measured from blood samples. Carotid IMT was measured using carotid duplex ultrasonography.

Results

Psoriatic patients showed significantly higher leptin levels and higher IMT than controls. The mean of the intima-media thickness of the four vessels examined (MIMT) showed a positive correlation with patients’ mean ages, disease duration, body mass index, PASI scores, systolic blood pressure, diastolic blood pressure, leptin levels, LDL levels and triglyceride levels and no correlation with the mean HDL level.

Conclusion

Psoriasis is an independent risk factor for subclinical atherosclerosis. This cardiovascular impairment is influenced mainly by disease severity, serum TG levels and serum leptin levels.

Zusammenfassung

Hintergrund

Psoriasis, eine chronisch-entzündliche Autoimmunkrankheit, wird mit erhöhter kardiovaskulärer Mortalität und Morbidität in Verbindung gebracht. Bei Leptin, einem adipositasbezogenen Peptid, wurde nachgewiesen, dass es eine direkte Wirkung auf Endothel und glatte Muskelzellen der Gefäße hat. Die Messung der Karotis-Intima-Media-Dicke („intima-media thickness“, IMT) ist ein vielversprechendes Instrument zur Erkennung der Arteriosklerose und ihrer präokklusiven/subklinischen Phase.

Ziel

Ziel der Studie war die Bestimmung der Karotis-IMT und des Serumleptinspiegels bei Psoriasispatienten als Indikator einer subklinischen Arteriosklerose.

Material und Methoden

Die Studie wurde mit 50 Psoriasispatienten und 10 gesunden Kontrollen durchgeführt. Bei den Patienten wurde der klinische Schweregrad der Hautaffektion anhand des PASI („psoriatic area and severity index“) erhoben. Anhand von Blutproben wurden Serumleptinspiegel (ng\ml) und Lipidprofile [einschließlich Triglyzeride (TG), LDL („low-density lipoprotein“) und HDL („high-density lipoprotein“) im Serum] gemessen. Die Karotis-IMT wurde mit der Karotisduplexsonographie ermittelt.

Ergebnisse

Bei den Psoriasispatienten waren signifikant höhere Leptinspiegel und eine höhere IMT als bei den Kontrollen nachzuweisen. Das Mittel der IMT für die vier untersuchten Gefäße zeigte eine positive Korrelation mit den Durchschnittswerten für Patientenalter, Krankheitsdauer, Body-Mass-Index, PASI, systolischem und diastolischem Blutdruck, Leptin, LDL und TG, aber keine Korrelation mit dem durchschnittlichen HDL-Wert.

Fazit

Psoriasis ist ein unabhängiger Risikofaktor für subklinische Arteriosklerose. Diese kardiovaskuläre Erkrankung wird hauptsächlich durch die Krankheitsschwere sowie die TG- und Leptinwerte im Serum beeinflusst.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Naldi L, Chatenoud L, Linder D et al (2005) Cigarette smoking, body mass index, and stressful life events as risk factors for psoriasis: results from an Italian case-control study. J Invest Dermatol 125:61–67

    Article  PubMed  CAS  Google Scholar 

  2. Otero M, Lago R, Lago F et al (2005) Leptin from fat to inflammation: old questions and new insights. FEBS Lett 579:295–301

    Article  PubMed  CAS  Google Scholar 

  3. Fujita Y, Murakami M, Ogawa Y et al (2002) Leptin inhibits stress-induced apoptosis of T lymphocytes. Clin Exp Immunol 128:21–26

    Article  PubMed  CAS  Google Scholar 

  4. Conus C, Bruno A, Simon HU (2005) Leptin is an eosinophil survivor factor. J Allergy Clin Immunol 116:1128–1134

    Article  Google Scholar 

  5. Aktan F, Rota S, Erdogan BS et al (2007) A Role of leptin in psoriasis? Turk J Med Sci 37(3):135–138

    CAS  Google Scholar 

  6. Parhami F, Tintut Y, Ballard A et al (2001) Leptin enhances the calcification of vascular cells: artery wall as a target of leptin. Circ Res 88:954–960

    Article  PubMed  CAS  Google Scholar 

  7. Reilly MP, Iqbal N, Schutta M et al (2004) Plasma leptin levels are associated with coronary athero-sclerosis in type 2 diabetes. J Clin Endocrinol Metab 89:3872–3878

    Article  PubMed  CAS  Google Scholar 

  8. Van der Vleuten GM, Veerkamp MJ, Tits LJ van et al (2005) Elevated leptin levels in subjects with familial combined hyperlipidemia are associated with the increased risk for CVD. Atherosclerosis 183:355–360

    Article  Google Scholar 

  9. Wallace AM, McMahon AD, Packard CJ, Kelly A et al (2001) Plasma leptin and the risk of cardiovascular disease in the west of Scotland coronary prevention study (WOSCOPS). Circulation 104:3052–3056

    Article  PubMed  CAS  Google Scholar 

  10. Kremers H, McEvoy M, Dann F et al (2007) Heart disease in psoriasis. J Am Acad Dermatol 57:347–354

    Article  PubMed  Google Scholar 

  11. Hansa G, Bhargava K, Bansal M et al (2003) Carotid intima-media thickness and coronary artery disease: an indian perspective. Asian Cardiovasc Thorac Ann 11:217–221

    PubMed  Google Scholar 

  12. Trigaux JP, Delchambre F, Van Beers (1990) B Anatomical variations of the carotid bifurcation: implications for digital subtraction angiography and ultrasonography. Br J Radiol 63:181–185

    Article  PubMed  CAS  Google Scholar 

  13. Patel MR, Kuntz KM, Klufas RA et al (1995) Preoperative assessment of the carotid bifurcation. Can magnetic resonance angiography and duplex ultrasonography replace contrast arteriography? Stroke 26:1753–1758

    Article  PubMed  CAS  Google Scholar 

  14. Moll J, Wright V (1973) Psoriatic arthritis. Semin Arthritis Rheum 3:55–78

    Article  PubMed  CAS  Google Scholar 

  15. Fredricksson T, Petterson U (1978) Severe psoriasis: oral therapy with a new retinoid. Dermatologica 157:238–244

    Article  Google Scholar 

  16. Shikiar R, William MK, Okun MM et al (2006) The validity and responsiveness of three quality of life measures in the assessment of psoriasis patients: results of phase II study. Health Qual Life Outcomes 4:71

    Article  PubMed  Google Scholar 

  17. Wikstrand J, Windelhag I (1994) Methodological considerations of ultrasound investigation of intima-media thickness and lumen diameter. J Int Med 236:555–559

    Article  CAS  Google Scholar 

  18. Mazlan SA, Bin Mohamed Said MS, Hussein H et al (2009) A study of intima media thickness and their cardiovascular risk factors in patients with psoriatic arthritis. Acta Medica (Hradec Kralove) 52(3):107–116

    Google Scholar 

  19. Peters MJ, Van der Horst-Bruinsma IE, Dijkmans BA et al (2004) Cardiovascular risk profile of patients with spondylarthropathies, particularly ankylosing spondylitis and psoriatic arthritis. Semin Arthritis Rheum 34:585–592

    Article  PubMed  Google Scholar 

  20. Sattar N, McInnes IB (2005) Vascular comorbidity in rheumatoid arthritis: potential mechanisms and solutions. Curr Opin Rheumatol 17:286–292

    Article  PubMed  Google Scholar 

  21. Youssef SS, Hosny S, Bakr I et al (2009) Susceptibility to atherosclerosis in patients with psoriasis and psoriatic arthritis as determined by increased carotid artery intima-media thickness. J Pan-Arab League of Dermatologists 20:159–172

    Google Scholar 

  22. Tanaka S, Inoue S, Isoda F et al (1993) Impaired immunity in obesity: suppressed but reversible lymphocyte responsiveness. Int J Obes Relat Metab Disord 17:631–636

    PubMed  CAS  Google Scholar 

  23. Tanaka S, Isoda F, Ishihara Y et al (2001) T lymphopaenia in relation to body mass index and TNF-alpha in human obesity: adequate weight reduction can be corrective. Clin Endocrinol 54:347–354

    CAS  Google Scholar 

  24. Chen Y, Wu C, Shen J et al (2008) Psoriasis independently associated with hyperleptinemia contributing to metabolic syndrome. Arch Dermatol 144:1571–1575

    Article  PubMed  Google Scholar 

  25. Cerman AA, Bozkurt S, Sav A et al (2008) Serum leptin levels, skin leptin and leptin receptor expression in psoriasis. Br J Dermatol 159:820–826

    Article  PubMed  CAS  Google Scholar 

  26. Wakkee M, Thio HB, Prens EP et al (2007) Unfavorable cardiovascular risk profiles in untreated and treated psoriasis patients. Atherosclerosis 190:1–9

    Article  PubMed  CAS  Google Scholar 

  27. O’Leary DH, Polak, JF, Kronmal, RA et al (1999) Carotid- artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. Cardiovascular health study collaborative research group. N Engl J Med 340:14–22

    Article  Google Scholar 

  28. Iribarren C, Husson G, Go AS et al (2007) Plasma leptin levels and coronary artery calcification in older adults. J Clin Endocrinol Metab 92:729–732

    Article  PubMed  CAS  Google Scholar 

  29. Singhal A, Farooqi IS, Cole TJ et al (2002) Influence of leptin on arterial distensibility: a novel link between obesity and cardiovascular disease? Circulation 106:1919–1924

    Article  PubMed  CAS  Google Scholar 

  30. Sierra-Honigmann MR, Nath AK, Murakami C, Garcia-Cardena G et al (1998) Biological action of leptin as an angiogenic factor. Science 281:1683–1686

    Article  PubMed  CAS  Google Scholar 

  31. Bouloumie A, Marumo T, Lafontan M et al (1999) Leptin induces oxidative stress in human endothelial cells. FASEB J 13:1231–1238

    PubMed  CAS  Google Scholar 

  32. Kang SM, Kwon HM, Hong BK et al (2000) Expression of leptin receptor (Ob-R) in human atherosclerotic lesions: potential role in intimal neovascularization. Yonsei Med J 41:68–75

    PubMed  CAS  Google Scholar 

  33. El-Mongy S, Fathy H, Abdelaziz A et al (2009) Subclinical atherosclerosis in patients with chronic psoriasis: a potential association. J Eur Acad Dermatol Venereol 24:661–666

    Article  PubMed  Google Scholar 

  34. Tam LS, Shang Q, Li EK et al (2008) Subclinical carotid atherosclerosis in patients with psoriatic arthritis. Arthritis Care Res 59:1322–1331

    Article  Google Scholar 

  35. Eder L, Zisman D, Barzilat M et al (2008) Subclinical atherosclerosis in psoriatic arthritis: a case-control study. J Rheumatol 35:877–882

    PubMed  Google Scholar 

  36. Hokanson JE, Austin MA (1996) Plasma triglyceride level is a risk factor for cardiovascular disease independent of high-density lipoprotein cholesterol level: a meta-analysis of population based prospective studies. J Cardiovasc Risk 3:213–219

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to B. Enany MD.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Enany, B., El Zohiery, A., Elhilaly, R. et al. Carotid intima-media thickness and serum leptin in psoriasis. Herz 37, 527–533 (2012). https://doi.org/10.1007/s00059-011-3547-z

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00059-011-3547-z

Keywords

Schlüsselwörter

Navigation